Clinical Trial Update: A Study of ADH300004 and 5-Fluorouracil in Locally Advanced, Recurrent, or Metastatic Hepatocellular Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study evaluating ADH300004 in combination with 5-Fluorouracil for hepatocellular carcinoma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• ADH300004 (ADH300004)

Snippet

Sponsor: Adherex Technologies, Inc. | Conditions: Hepatocellular Carcinoma | Phase 1, Phase 2 | Status: TERMINATED